Related references
Note: Only part of the references are listed.The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials
Tobias W. Klausen et al.
LEUKEMIA (2019)
A clinical prediction model for outcome and therapy delivery in transplant-ineligible patients with myeloma (UK Myeloma Research Alliance Risk Profile): a development and validation study
Gordon Cook et al.
LANCET HAEMATOLOGY (2019)
Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial
Graham H. Jackson et al.
LANCET ONCOLOGY (2019)
Multiple myeloma: 2018 update on diagnosis, risk-stratification, and management
S. Vincent Rajkumar
AMERICAN JOURNAL OF HEMATOLOGY (2018)
A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients
Monika Engelhardt et al.
HAEMATOLOGICA (2017)
A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients
Monika Engelhardt et al.
HAEMATOLOGICA (2017)
Myeloma prognostic index at diagnosis might be a prognostic marker in patients newly diagnosed with multiple myeloma
Dae Sik Kim et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2017)
The Danish National Multiple Myeloma Registry
Peter Gimsing et al.
CLINICAL EPIDEMIOLOGY (2016)
Prognostic Effect of Comorbidity Indices in Elderly Patients With Multiple Myeloma
Jelena Bila et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2015)
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
Antonio Palumbo et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Hematopoietic Cell Transplant Comorbidity Index Is Predictive of Survival after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma
Ayman Saad et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation
Gareth J. Morgan et al.
BLOOD (2011)
International staging system for multiple myeloma
PR Greipp et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Share Paper
